Tuesday Pre-Market Insights: GLNG, ACRX, QLYS, EIGI
Golar LNG Limited (USA) (NASDAQ:GLNG) increased more than 17% in pre-market trading to $44.27 after the shipping company was chosen as a partner for the Fortuna FLNG project with Ophir Energy Plc.
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) lost 26% in pre-market trading, sending shares down to $41.79 after the FDA restated that Zalviso, AcelRx’s pain killer device, needed more testing to prove safety and efficacy and declined to meet with ACRX.
Qualys Inc (NASDAQ:QLYS) fell nearly 25%to $41.79 following the release of 1Q15 earnings which outlined a disappointing outlook.
Endurance International Group Hldgs Inc (NASDAQ:EIGI) shares fell 7.5% to $18.50 after the cloud technology company posted 1Q15 earnings with a loss of ($0.15), compared to analysts’ expectations of $0.30 earnings per share.